Carbios SA
F:3C1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Carbios SA
F:3C1
|
FR |
|
F
|
freenet AG
DUS:FNTN
|
DE |
|
Dana Brata Luhur Tbk PT
IDX:TEBE
|
ID |
|
D
|
Dr Ing hc F Porsche AG
DUS:P911
|
DE |
|
S
|
Supreme Petrochem Ltd
BSE:500405
|
IN |
|
Alpha HPA Ltd
F:3AU
|
AU |
|
Telesat Corp
F:ZE2
|
CA |
|
Gap Inc
NYSE:GAP
|
US |
|
Aptose Biosciences Inc
OTC:APTOF
|
CA |
|
S
|
SSE PLC
XMUN:SCT
|
UK |
|
A
|
Andritz AG
XMUN:AZ2
|
AT |
|
B
|
Biotest AG
F:BIO
|
DE |
|
Ynvisible Interactive Inc
XTSX:YNV
|
CA |
Wall St Price Targets
3C1 Price Targets Summary
Carbios SA
According to Wall Street analysts, the average 1-year price target for
3C1 is 10.53 EUR with a low forecast of 10.43 EUR and a high forecast of 10.84 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 3C1's stock price target?
Price Target
10.53
EUR
According to Wall Street analysts, the average 1-year price target for
3C1 is 10.53 EUR with a low forecast of 10.43 EUR and a high forecast of 10.84 EUR.
What is the Revenue forecast for Carbios SA?
Projected CAGR
303%
Over the last 11 years, the compound annual growth rate for Revenue has been -16%. The projected CAGR for the next 4 years is 303%.